Atsushi Ogata Selected Research

Experimental Arthritis

5/2015	Leucine-rich α2 -glycoprotein as a potential biomarker for joint inflammation during anti-interleukin-6 biologic therapy in rheumatoid arthritis.
1/2009	Imatinib mesylate inhibited rat adjuvant arthritis and PDGF-dependent growth of synovial fibroblast via interference with the Akt signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Atsushi Ogata Research Topics

Disease

26	Rheumatoid Arthritis 01/2021 - 06/2003
9	Arthritis (Polyarthritis) 06/2015 - 05/2003
5	Hemorrhage 03/2024 - 01/2017
5	Multiple Myeloma 12/2007 - 01/2002
4	Ischemic Stroke 03/2024 - 09/2019
4	Systemic Scleroderma (Systemic Sclerosis) 01/2015 - 06/2003
4	Autoimmune Diseases (Autoimmune Disease) 02/2014 - 01/2004
3	Stroke (Strokes) 01/2023 - 09/2014
3	Psoriatic Arthritis 01/2021 - 01/2012
3	Carotid Stenosis (Carotid Artery Stenosis) 03/2020 - 06/2018
3	Infections 03/2019 - 01/2012
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2012 - 01/2004
2	Hypertension (High Blood Pressure) 01/2023 - 11/2010
2	Neoplasms (Cancer) 01/2019 - 12/2007
2	Inflammation (Inflammations) 05/2015 - 01/2012
2	Experimental Arthritis 05/2015 - 01/2009
2	Castleman Disease (Castleman's Disease) 03/2015 - 02/2014
2	Polymyositis 01/2012 - 07/2011
2	Seasonal Allergic Rhinitis (Hay Fever) 09/2009 - 01/2009
2	Asthma (Bronchial Asthma) 06/2007 - 04/2006
2	Bone Diseases (Bone Disease) 01/2005 - 01/2002
1	Brain Edema (Cerebral Edema) 03/2024
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 03/2024
1	Cerebral Small Vessel Diseases 01/2023
1	Carcinogenesis 04/2022
1	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2022
1	Pain (Aches) 01/2022
1	COVID-19 01/2022
1	Intracranial Embolism 07/2021
1	Aneurysm (Aneurysms) 07/2021
1	Patent Foramen Ovale 07/2021
1	Hemorrhagic Stroke 10/2020
1	Primary Myelofibrosis (Myelosclerosis) 01/2020
1	Cytopenia 01/2020
1	Dyslipidemias (Dyslipidemia) 03/2019
1	Thrombocytopenia (Thrombopenia) 03/2019
1	Intestinal Perforation 03/2019
1	Neutropenia 03/2019
1	Prolactinoma (Prolactinomas) 01/2019
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Myocardial Infarction 01/2019
1	Rheumatic Fever (Acute Articular Rheumatism) 01/2019
1	Spinal Dysraphism (Spina Bifida) 01/2018
1	Scoliosis 01/2018
1	Hypoxia (Hypoxemia) 06/2017
1	Brain Neoplasms (Brain Tumor) 06/2017

Drug/Important Bio-Agent (IBA)

23	tocilizumab (atlizumab)FDA Link 09/2019 - 12/2009
9	Interleukin-6 (Interleukin 6)IBA 03/2019 - 10/2007
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2003
5	Monoclonal AntibodiesIBA 01/2019 - 01/2012
4	AntibodiesIBA 01/2022 - 03/2014
4	C-Reactive ProteinIBA 03/2019 - 05/2003
4	Tumor Necrosis Factor InhibitorsIBA 01/2014 - 11/2010
3	Peptides (Polypeptides)IBA 01/2021 - 12/2007
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2017 - 03/2002
3	FlavonoidsIBA 09/2009 - 06/2007
3	Interleukin-18 (Interleukin 18)IBA 04/2006 - 05/2003
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 06/2003 - 03/2002
2	AntigensIBA 03/2020 - 04/2010
2	Glycophorins (Glycophorin C)IBA 03/2020 - 06/2018
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 08/2011
2	EnzymesIBA 03/2019 - 11/2010
2	LigandsIBA 01/2019 - 12/2007
2	Leucine (L-Leucine)FDA Link 05/2015 - 04/2010
2	Glycoproteins (Glycoprotein)IBA 05/2015 - 04/2010
2	Methotrexate (Mexate)FDA LinkGeneric 01/2015 - 11/2010
2	Antirheumatic Agents (DMARD)IBA 03/2014 - 11/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012 - 01/2012
2	GlycosidesIBA 09/2009 - 01/2009
2	isoquercitrinIBA 09/2009 - 01/2009
2	QuercetinIBA 09/2009 - 01/2009
2	Diphosphonates (Bisphosphonates)IBA 01/2005 - 01/2002
1	IodineIBA 03/2024
1	Amyloid (Amyloid Fibrils)IBA 01/2023
1	antiglomerular basement membrane antibodyIBA 04/2022
1	NucleotidesIBA 01/2021
1	CalreticulinIBA 10/2020
1	Coloring Agents (Dyes)IBA 03/2020
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2019
1	ProlactinIBA 01/2019
1	Cabergoline FDA LinkGeneric 01/2019
1	General AnestheticsIBA 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	alirocumabIBA 01/2019
1	Proprotein Convertase 9IBA 01/2019
1	PCSK9 InhibitorsIBA 01/2019
1	LipidsIBA 01/2019
1	LDL CholesterolIBA 01/2019
1	Interleukin-8 (Interleukin 8)IBA 01/2019
1	Certolizumab Pegol FDA Link 01/2018

Therapy/Procedure

14	Therapeutics 04/2022 - 01/2005
3	Thrombectomy 03/2024 - 09/2019
3	Carotid Endarterectomy 03/2020 - 06/2017
3	Drug Therapy (Chemotherapy) 06/2017 - 01/2002
1	Microvascular Decompression Surgery 01/2022
1	Orthopedic Procedures 07/2021
1	Stents 01/2021
1	Catheters 11/2020
1	Cardiopulmonary Resuscitation (CPR) 01/2018